SteerX Ventures funding is built for one sector only: healthcare. SteerX Ventures is a healthcare-focused venture capital fund based in India, investing from pre-seed through Series A across care delivery, diagnostics, digital health and medical technology. It is led by founder and CEO Lalit Singla, and its site describes it as a group of healthcare CXOs, founders, medical doctors and investors on a mission to redefine the future of healthcare — with what it calls India's first SEBI-registered healthcare Venture Capital (Angel) Fund.
SteerX Ventures funding: thesis and sectors
The thesis is that healthcare is a high-potential but under-penetrated sector where deep operating expertise beats generalist capital. SteerX says it invests "where it matters the most", backing early-stage disruptive startups and supporting their growth journeys with hands-on guidance from experienced healthcare operators, CXOs and investors. It focuses on care delivery, diagnostics, digital health and medtech, backing teams with a compelling need, real differentiation, strong market validation and scale potential.
Fund size and cheque size
SteerX's fund size is not publicly disclosed. Its deal rhythm is early-stage: it led the $1.1 million pre-seed round in CureMeAbroad in October 2026 and led an undisclosed seed round in teleconsultation platform MyRx in September 2026 — consistent with a pre-seed to seed lead-investor posture.
Notable portfolio companies
The headline deal is CureMeAbroad (operated by Luxora Health Care Experiences Pvt. Ltd., Pune): the cross-border healthcare platform raised $1.1 million in a pre-seed round led by SteerX Ventures with participation from existing investor AIRA, announced 6 October 2026. Founded in June 2025 by cousins Aditya Oza (CEO) and Mikhail Bohra (CMO), the platform lets patients compare and book treatment at vetted hospitals abroad — with more than 22,500 monthly visitors, a network of 400+ accredited hospitals across six countries, a $4.8 million annualised treatment-booking run rate and a $100 million FY28 bookings target. It had earlier raised $600,000 in April 2026 from angels including Unacademy's Roman Saini, ex-Cars24 India's Himanshu Ratnoo and EMotorad's Kunal Gupta. SteerX also led the seed round in MyRx (Platinoid Technologies, Hyderabad), founded by Sourav Das, Surjit Das and Neel Rath, which provides teleconsultation-as-a-service and reports around 35,000 teleconsultations a day.
Team and leadership
Founder and CEO Lalit Singla leads the firm, which presents itself as a collective of healthcare CXOs, founders, doctors and investors. Oza of CureMeAbroad noted that Singla's team "understood the mechanics of value travel" well enough that their first conversation skipped the education and went straight to accountability at scale.
Programmes, credits and perks
SteerX's stated offering to startups: funding, expert mentorship, global expansion support and strategic partnerships — including access to an ecosystem of hospitals, doctors and industry partners to sharpen go-to-market. For investors, it offers an invite-only network of healthcare thought leaders. No public startup-credit scheme is advertised.
How to apply for funding
SteerX's official site (steerx.vc) has Startups and Contact us pages — founders should reach out through the site's contact route describing their healthcare venture. There is no public application form detailed in coverage, so a crisp, sector-native pitch through the contact page or a warm introduction via the healthcare ecosystem is the practical route.
Why it matters for founders
SteerX is one of the few India funds that only does healthcare — and its CureMeAbroad and MyRx deals show it leads early rounds, not just follows. If you are building in care delivery, diagnostics, digital health or medtech and want an investor that speaks the sector's language, Lalit Singla's team should be on your pre-seed and seed list.